Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$58.20
neg -1.27
-2.14%
Today's Range: 57.94 - 59.29 | BMY Avg Daily Volume: 6,618,100
Last Update: 09/01/15 - 4:02 PM EDT
Volume: 8,830,762
YTD Performance: 0.75%
Open: $58.54
Previous Close: $59.47
52 Week Range: $47.55 - $70.54
Oustanding Shares: 1,667,502,766
Market Cap: 101,067,342,647
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 5 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 1 2 1
Mean Rec. 1.75 1.89 2.10 1.89
Latest Dividend: 0.37
Latest Dividend Yield: 2.44%
Dividend Ex-Date: 07/01/15
Price Earnings Ratio: 56.64
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
56.64 56.80 25.39
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.94% 17.41% 80.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 -0.25 -0.09
Net Income -21.40 -0.61 -0.27
EPS -22.20 -0.44 -0.18
Earnings for BMY:
EBITDA 3.06B
Revenue 15.88B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.34 $0.22 $1.81 $2.24
Number of Analysts 10 8 12 13
High Estimate $0.40 $0.27 $1.93 $2.49
Low Estimate $0.27 $0.13 $1.74 $2.05
Prior Year $0.45 $0.46 $1.85 $1.81
Growth Rate (Year over Year) -24.22% -51.90% -2.03% 23.71%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Aug 24, 2015 | 6:55 AM EDT
BMY was upgraded from Underweight to Neutral, Piper Jaffray said. Valuation call, based on a $61 price target. 
To see where this market is going, I have to go back to the days when I ran a half-billion-dollar hedge fund.
Not many, according to filings from Tweedy Browne and Kahn Brothers.
Just like Apple, other companies are affected by China.
Tech, telecom stocks lead major averages lower.
Futures are mixed as quarterly results begin to obscure Greece.
IPO makes big debut as Google soars.
This market is almost entirely special situation.
Is there also a lot on the line for the U.S.?
Stock is showing short-term positive price momentum.

Columnist Conversations

A wild ride lies ahead. I am reducing my "Fair Market Value" of the S and P Index to 1835- four percent below ...
Today's Takeaways and Observations coming up - as I fly, like my Gnome, high above the Rockies!
As the market broke hard today we added some more puts on the indices and high flyers NFLX and AAPL. 1920 on ...
It's an ugly market today with the DJIA -400 and high beta stocks like $AMBA Ambarella down 7%. Oil and energy...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.